Diverging EU Health Regulations: The urgent need for coordination and convergence

Clinical research is bound to very complex legal framework. The article “Diverging EU Health Regulations: The urgent need for coordination and convergence” urges the European Commission to take actions and harmonize these legislations.

The three article’s authors: EORTC Director General, Denis Lacombe; EORTC Director of Special Projects, Françoise Meunier and EORTC Head of International Policy Department & DPO, Anastassia Negrouk are giving their opinion.

The article is available online, containing full bibliographic details.


Back to news list

Related News

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

  • EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023